Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
2000 3
2001 5
2002 2
2003 5
2004 5
2005 3
2006 5
2007 4
2008 4
2009 2
2010 1
2011 2
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Invasion of the killer B's in type 1 diabetes.
Silveira PA, Serreze DV, Grey ST. Silveira PA, et al. Front Biosci. 2007 Jan 1;12:2183-93. doi: 10.2741/2221. Front Biosci. 2007. PMID: 17127455 Review.
The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
DiLorenzo TP, Serreze DV. DiLorenzo TP, et al. Immunol Rev. 2005 Apr;204:250-63. doi: 10.1111/j.0105-2896.2005.00244.x. Immunol Rev. 2005. PMID: 15790363 Review.
Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice.
Serreze DV, Leiter EH. Serreze DV, et al. Curr Dir Autoimmun. 2001;4:31-67. doi: 10.1159/000060527. Curr Dir Autoimmun. 2001. PMID: 11569409 Review. No abstract available.
Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice.
Pearson T, Markees TG, Serreze DV, Pierce MA, Wicker LS, Peterson LB, Shultz LD, Mordes JP, Rossini AA, Greiner DL. Pearson T, et al. Rev Endocr Metab Disord. 2003 Sep;4(3):255-61. doi: 10.1023/a:1025152312496. Rev Endocr Metab Disord. 2003. PMID: 14501176 Review. No abstract available.
Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice.
Chen YG, Scheuplein F, Driver JP, Hewes AA, Reifsnyder PC, Leiter EH, Serreze DV. Chen YG, et al. J Immunol. 2011 Apr 1;186(7):4278-84. doi: 10.4049/jimmunol.1003733. Epub 2011 Feb 25. J Immunol. 2011. PMID: 21357538 Free PMC article.
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice.
Silveira PA, Dombrowsky J, Johnson E, Chapman HD, Nemazee D, Serreze DV. Silveira PA, et al. J Immunol. 2004 Apr 15;172(8):5086-94. doi: 10.4049/jimmunol.172.8.5086. J Immunol. 2004. PMID: 15067092 Free PMC article.
In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
Jarchum I, Baker JC, Yamada T, Takaki T, Marron MP, Serreze DV, DiLorenzo TP. Jarchum I, et al. Diabetes. 2007 Oct;56(10):2551-60. doi: 10.2337/db07-0332. Epub 2007 Jul 9. Diabetes. 2007. PMID: 17620420 Free article.
CD38 is required for the peripheral survival of immunotolerogenic CD4+ invariant NK T cells in nonobese diabetic mice.
Chen YG, Chen J, Osborne MA, Chapman HD, Besra GS, Porcelli SA, Leiter EH, Wilson SB, Serreze DV. Chen YG, et al. J Immunol. 2006 Sep 1;177(5):2939-47. doi: 10.4049/jimmunol.177.5.2939. J Immunol. 2006. PMID: 16920929 Free article.
Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.
Mangada J, Pearson T, Brehm MA, Wicker LS, Peterson LB, Shultz LD, Serreze DV, Rossini AA, Greiner DL. Mangada J, et al. Diabetes. 2009 Jan;58(1):165-73. doi: 10.2337/db08-0275. Epub 2008 Nov 4. Diabetes. 2009. PMID: 18984741 Free PMC article.
During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities.
DiLorenzo TP, Lieberman SM, Takaki T, Honda S, Chapman HD, Santamaria P, Serreze DV, Nathenson SG. DiLorenzo TP, et al. Clin Immunol. 2002 Dec;105(3):332-41. doi: 10.1006/clim.2002.5298. Clin Immunol. 2002. PMID: 12498815
41 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback